The Foundation is proud to officially partner with United Nations Institute for Training and Research (UNITAR) through a new Memorandum of Understanding, bringing the voice of the GBS, CIDP, MMN, and related conditions community to the global Plasma4Life initiative.
For those living with immune-mediated neuropathies, access to plasma-derived medicinal products can mean the difference between uncertainty and hope.
Together with UNITAR, we are advancing awareness, collaboration, and more equitable healthcare solutions for patients and families worldwide.
Learn more: https://hemostasistoday.com/voices/nancy-di-salvo-72336
Other Articles You May Like
Speaker Series: Estrangement & Isolation, Chronic Illness
Living with a chronic illness can affect much more than physical health—it can also impact…
GBS|CIDP Legislative Agenda 2026 | Advocacy Priorities
Support Robust Research Funding Currently, there is no cure for GBS, CIDP, or MMN. Patients…
CIDP Real-World Experience
Research Study Opportunity: CIDP Real-World Experience For more information: https://cidpresearchstudy.com/ A new research study is…